Hits:

Indexed by:Journal Papers

Date of Publication:2020-03-01

Journal:BIOMATERIALS

Included Journals:PubMed、EI、SCIE

Volume:233

Page Number:119755

ISSN No.:0142-9612

Key Words:tumor hypoxia; Chemo-PDT; Catalase; Immunosuppressive TME; Folate receptor targeting

Abstract:Photodynamic therapy (PDT) and chemotherapy has been applied as a prospective approach in tumor therapeutics. However, suffering from the inherent hypoxia status in tumor microenvironment (TME), the anticancer efficiency is enormously restricted, especially PDT. Herein, we develop a unique liposomal encapsulated catalase (CAT), lyso-targeted NIR photosensitizer (MBDP) and doxorubicin (Dox), forming FA-L@MD@CAT, to increase tumor oxygenation by catalyzing intratumoral high-expressed H2O2 for enhancing the combination of chemoPDT. Moreover, the enhanced tumoral oxygenation not only facilitates singlet oxygen (O-1(2)) production but also reverses immunosuppressive TME by modulating immune cytokines to favor antitumor immunities, which significantly induce tumor death. Notably, this system also realizes specific tumor recognition to folate receptor upregulated tumors and improves intratumoral accumulation. This work provides an effective strategy to promote tumor therapeutic index, which may possess a promising future in clinical application.